FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309508178> ?p ?o ?g. }

• W4309508178 endingPage "28" @default.
• W4309508178 startingPage "22" @default.
• W4309508178 abstract "The transcription factor hypoxia-inducible factor 1α (HIF-1α) is expressed in several cancers under intratumoral hypoxic stress that arises during pathogenic processes, resulting in malignant progression. We previously reported that hypoxic stimulation enhances the growth potential of canine lymphoma cells by activating the HIF-1α signaling pathway. In contrast, evofosfamide (Evo) releases a DNA-alkylating moiety within hypoxic tumor regions, suggesting that Evo could serve as a hypoxia-targeting drug in canine lymphoma. This study aimed to use Evo to evaluate hypoxia-targeted therapy in dogs with gastrointestinal lymphoma (GIL) and investigate how Evo affects antitumor efficacy and adverse events in three type of murine xenograft models using T-cell GIL cells. In vitro tests, the sensitivity to Evo of three T-cell GIL cell lines under hypoxic culture was significantly higher than that under normoxic culture. Our metabolic analysis suggested that the three murine models might have high reproducibility as clinical cases in canine GIL. Our data showed that Evo showed significantly higher tumor growth potential and fewer adverse events in three type of murine models compared to lomustine; CeeNu (CCNU). Additionally, Evo suppressed the expression of HIF-1α protein in tumor tissues, suggesting that it may preferentially target and inhibit tumor cells in a hypoxic region. The evidence presented here supports the favorable preclinical evaluation that Evo may be effective for GIL in dogs." @default.
• W4309508178 created "2022-11-28" @default.
• W4309508178 creator A5005335382 @default.
• W4309508178 creator A5010214111 @default.
• W4309508178 creator A5048639658 @default.
• W4309508178 creator A5072033181 @default.
• W4309508178 creator A5074433426 @default.
• W4309508178 date "2023-01-01" @default.
• W4309508178 modified "2023-09-25" @default.
• W4309508178 title "Assessment of hypoxia-targeting therapy for gastrointestinal lymphoma in dogs: Preclinical test using murine models" @default.
• W4309508178 cites W1964891521 @default.
• W4309508178 cites W1999459672 @default.
• W4309508178 cites W2025792697 @default.
• W4309508178 cites W2034072253 @default.
• W4309508178 cites W2035266548 @default.
• W4309508178 cites W2045391305 @default.
• W4309508178 cites W2069698188 @default.
• W4309508178 cites W2104928951 @default.
• W4309508178 cites W2137210843 @default.
• W4309508178 cites W2139036362 @default.
• W4309508178 cites W2142292357 @default.
• W4309508178 cites W2164942973 @default.
• W4309508178 cites W2172140349 @default.
• W4309508178 cites W2255357451 @default.
• W4309508178 cites W2359012815 @default.
• W4309508178 cites W2612264767 @default.
• W4309508178 cites W2791520935 @default.
• W4309508178 cites W2804744141 @default.
• W4309508178 cites W2808190774 @default.
• W4309508178 cites W3037744540 @default.
• W4309508178 cites W3126639783 @default.
• W4309508178 cites W3153976540 @default.
• W4309508178 cites W4290804342 @default.
• W4309508178 cites W631016180 @default.
• W4309508178 doi "https://doi.org/10.1016/j.rvsc.2022.11.003" @default.
• W4309508178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36403333" @default.
• W4309508178 hasPublicationYear "2023" @default.
• W4309508178 type Work @default.
• W4309508178 citedByCount "0" @default.
• W4309508178 crossrefType "journal-article" @default.
• W4309508178 hasAuthorship W4309508178A5005335382 @default.
• W4309508178 hasAuthorship W4309508178A5010214111 @default.
• W4309508178 hasAuthorship W4309508178A5048639658 @default.
• W4309508178 hasAuthorship W4309508178A5072033181 @default.
• W4309508178 hasAuthorship W4309508178A5074433426 @default.
• W4309508178 hasConcept C126322002 @default.
• W4309508178 hasConcept C142724271 @default.
• W4309508178 hasConcept C178790620 @default.
• W4309508178 hasConcept C185592680 @default.
• W4309508178 hasConcept C203014093 @default.
• W4309508178 hasConcept C2776694085 @default.
• W4309508178 hasConcept C2776755627 @default.
• W4309508178 hasConcept C2779081379 @default.
• W4309508178 hasConcept C2779338263 @default.
• W4309508178 hasConcept C2779429289 @default.
• W4309508178 hasConcept C2779434656 @default.
• W4309508178 hasConcept C2908752941 @default.
• W4309508178 hasConcept C502942594 @default.
• W4309508178 hasConcept C509974204 @default.
• W4309508178 hasConcept C540031477 @default.
• W4309508178 hasConcept C54355233 @default.
• W4309508178 hasConcept C71924100 @default.
• W4309508178 hasConcept C7836513 @default.
• W4309508178 hasConcept C81885089 @default.
• W4309508178 hasConcept C86803240 @default.
• W4309508178 hasConcept C98274493 @default.
• W4309508178 hasConceptScore W4309508178C126322002 @default.
• W4309508178 hasConceptScore W4309508178C142724271 @default.
• W4309508178 hasConceptScore W4309508178C178790620 @default.
• W4309508178 hasConceptScore W4309508178C185592680 @default.
• W4309508178 hasConceptScore W4309508178C203014093 @default.
• W4309508178 hasConceptScore W4309508178C2776694085 @default.
• W4309508178 hasConceptScore W4309508178C2776755627 @default.
• W4309508178 hasConceptScore W4309508178C2779081379 @default.
• W4309508178 hasConceptScore W4309508178C2779338263 @default.
• W4309508178 hasConceptScore W4309508178C2779429289 @default.
• W4309508178 hasConceptScore W4309508178C2779434656 @default.
• W4309508178 hasConceptScore W4309508178C2908752941 @default.
• W4309508178 hasConceptScore W4309508178C502942594 @default.
• W4309508178 hasConceptScore W4309508178C509974204 @default.
• W4309508178 hasConceptScore W4309508178C540031477 @default.
• W4309508178 hasConceptScore W4309508178C54355233 @default.
• W4309508178 hasConceptScore W4309508178C71924100 @default.
• W4309508178 hasConceptScore W4309508178C7836513 @default.
• W4309508178 hasConceptScore W4309508178C81885089 @default.
• W4309508178 hasConceptScore W4309508178C86803240 @default.
• W4309508178 hasConceptScore W4309508178C98274493 @default.
• W4309508178 hasFunder F4320334764 @default.
• W4309508178 hasLocation W43095081781 @default.
• W4309508178 hasLocation W43095081782 @default.
• W4309508178 hasOpenAccess W4309508178 @default.
• W4309508178 hasPrimaryLocation W43095081781 @default.
• W4309508178 hasRelatedWork W1620593546 @default.
• W4309508178 hasRelatedWork W1973101600 @default.
• W4309508178 hasRelatedWork W2009153345 @default.
• W4309508178 hasRelatedWork W2081244579 @default.
• W4309508178 hasRelatedWork W2097820058 @default.
• W4309508178 hasRelatedWork W2109116750 @default.

• next